Article
Clinical utility of polygenic risk scores: a critical 2023 appraisal
3 May 2023
Abstract excerpt
Since their first appearance in the context of schizophrenia and bipolar disorder in 2009, polygenic risk scores (PRSs) have been described for a large number of common complex diseases. However, the clinical utility of PRSs in disease risk assessment or therapeutic decision making is likely limited because PRSs usually only account for the heritable component of a trait and ignore the etiological role of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
